MedTrace Logo

Bioimpedance-Guided Diuretics and Cardiac Progression in Asymptomatic Heart Failure

NCT07801144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-09-03

No results posted yet for this study

Summary

It has not been clearly elucidated whether volume control with diuretics is essential at an early stage in patients with heart failure (HF). This prospective study aims to assess the effects of diuretic treatment in systolic HF patients who have no clinical signs of congestion but have hypervolemia as measured by bioimpedance analysis (BIA). The study compares the outcomes of patients receiving bioimpedance-guided diuretic therapy to maintain negative hydration versus those followed without diuretic therapy over a 1-year period.

Conditions

Sponsors & Collaborators

  • Kayseri Training and Research Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2020-08-20
Completion
2020-11-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07801144 on ClinicalTrials.gov